Latest Report Available at Orbis research Vertigo Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.
Request sample copy of this report @ http://www.orbisresearch.com/contacts/request-sample/541121 .
Vertigo is a medical condition where a person feels as if they or the objects around them are moving when they are not. Often it feels like a spinning or swaying movement. This may be associated with nausea, vomiting, sweating, or difficulties walking. It is typically worsened when the head is moved. Vertigo is the most common type of dizziness. The causes for vertigo can be divided into two categories: Peripheral and Central. Peripheral is linked to the inner ear whereas central is linked to problems in Central Nervous System.
Peripheral vertigo can be further segmented into five major categories: Benign paroxysmal positional vertigo (BPPV), Acute Unilateral Vestibulopathy, Meniere’s disease and Vestibular Schwannoma. Amongst all the stated indication, Meniere’s disease represents the largest growth opportunity for the market players with its continuously rising incidence.
Growth of global vertigo market is expected to be driven by factors such as rising incidence and prevalence of peripheral etiologies of vertigo, increasing geriatric population, growing healthcare expenditure and improving disposable income. Further, the market growth could be hindered by side effects of currently prescribed medication, the high cost of treatment and tedious drug approval process. The key trends for the market include extensive research & development and different approaches being adopted by drug manufacturers in order to target vertigo.
A key drug Otividex, which is currently in third phase of clinical trials and is being developed by Otonomy Inc., is discussed in the report. The drug is easier to use and provides a higher and sustained concentration of dexamethasone relative to existing injections. Further, it is anticipated to provide a well-accepted treatment option for Meniere’s Disease, if successfully developed.
The report “Global Vertigo Market: Industry Analysis & Outlook (2017-2021)” analyzes the development of this market, with focus on Europe and US regions. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players involved in the development of breakthrough drug therapy for vertigo: Auris Medical Holding AG., Sensorion SA, Otonomy, Inc. and Sound Pharmaceuticals, Inc. are being profiled along with their key financials and strategies for growth.
Browse Complete Report @ http://www.orbisresearch.com/reports/index/global-vertigo-market-industry-analysis-and-outlook-2017-2021 .
Some points From TOC:
- Introduction
1.1 Vertigo
1.2 Causes & Types
1.3 Diagnosis & Treatment - Global Vertigo Market
2.1 Global Recurrent Vestibular Vertigo Patient Forecast
2.2 Global Treatable Vertigo Patient by Indication
2.3 Global Treatable Vertigo Patient by Region
2.4 Global Treatable Vertigo Episodes by Region
2.5 Global Meniere’s disease Market
2.5.1 Global Meniere’s disease Patient Forecast
2.5.2 Global Meniere’s disease Patient by Region
2.5.3 Global Otividex Drug Sales Forecast - Regional Market
3.1 Europe
3.1.1 Europe Recurrent Vestibular Vertigo Patient Forecast
3.1.2 Europe Treatable Vertigo Patient by Indication
3.1.3 Europe Meniere’s Disease Patient Forecast
3.1.4 Europe Otividex Drug Sales Forecast
3.2 The US
3.2.1 The US Recurrent Vestibular Vertigo Patient Forecast
3.2.2 The US Treatable Vertigo Patient by Indication
3.2.3 The US Meniere’s disease Patient Forecast
3.2.4 The US Meniere’s Disease Patient Eligible for Steroid Injections
3.2.5 The US Otividex Sales Forecast
Purchase a copy of Vertigo Market visit @ http://www.orbisresearch.com/contact/purchase/541121 For more information contact sales@orbisresearch.com .
- Market Dynamics
4.1 Growth Drivers
4.1.1 Growing Patient Population
4.1.2 Rising Geriatric Population
4.1.3 Increasing Healthcare Expenditure
4.1.4 Rising Disposable Income
4.2 Key Trends & Development
4.2.1 Extensive R&D Expenditure
4.2.2 Players Adopting Different Approaches for Drug Mechanism
4.3 Key Challenges
4.3.1 Hasty Drug Approval Process
4.3.2 Side Effects of the Current Therapies
4.3.3 High Cost - Competitive Landscape
5.1 Global Vertigo Market
5.1.1 Market Cap. Comparison by Companies
5.1.2 Product Comparison by Companies - Company Profiles
6.1 Auris Medical Holding AG
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Sensorion SA
6.2.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategy
6.3 Otonomy, Inc.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategy
6.4 Sound Pharmaceuticals, Inc.
6.4.1 Business Overview
6.4.2 Business Strategy
For any enquires before buying, connect with us @ enquiry@orbisresearch.com
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115
No comments:
Post a Comment